Filtered By:
Specialty: Cardiology
Drug: Pradaxa
Countries: Saudi Arabia Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 2 results found since Jan 2013.

Appropriateness of dabigatran dosing in patients with nonvalvular atrial fibrillation (NVAF): A retrospective study conducted in a tertiary care university hospital in the eastern province of Saudi Arabia
ConclusionThis study revealed inappropriate prescription of reduced doses of dabigatran in a large number of patients. Age was identified as the main driving factor for underdosing. Physicians’ and pharmacists’ awareness regarding this type of high-risk medication should be improved to ensure appropriate and safe use of this commonly used drug.
Source: Journal of the Saudi Heart Association - May 29, 2019 Category: Cardiology Source Type: research

Appropriateness of dabigatran dosing in patients with non-valvular atrial fibrillation (NVAF): A retrospective study conducted in a tertiary care university hospital in the Eastern Province of Saudi Arabia
ConclusionThis study revealed inappropriate prescription of reduced doses of dabigatran in a large number of patients. Age was identified as the main driving factor for underdosing. Physicians’ and pharmacists’ awareness regarding this type of high-risk medication should be improved to ensure appropriate and safe use of this commonly used drug.
Source: Journal of the Saudi Heart Association - May 17, 2019 Category: Cardiology Source Type: research